RecruitingNCT07629349

Dementia With Lewy Bodies: Clinical Symptoms, Biomarkers and Progression

Sponsor

Karolinska Institutet

Enrollment

600 participants

Start Date

Jan 1, 2020

Study Type

OBSERVATIONAL

Conditions

Mild Cognitive Impairment (MCI)Other Dementias Cognitively Unimpaired Dementia With Lewy Bodies (DLB)

Summary

The goal of this observational study is to improve the detection of dementia with Lewy bodies (DLB) and its prodromal phases, as well as advancing our current understanding of biological mechanisms and therapeutic options. The data is acquired at cognitive clinics in Stockholm (Sweden) and combined with national and international data to increase statistical power, representativeness and replication of results. Participants undergo collection of clinical assessments, neuroimaging and fluid biomarkers.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with cognitively unimpaired, dementia with lewy bodies (dlb), and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.